↓ Skip to main content

Dove Medical Press

qEEG as Biomarker for Alzheimer’s Disease: Investigating Relative PSD Difference and Coherence Analysis

Overview of attention for article published in Neuropsychiatric Disease and Treatment, November 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
6 Mendeley
Title
qEEG as Biomarker for Alzheimer’s Disease: Investigating Relative PSD Difference and Coherence Analysis
Published in
Neuropsychiatric Disease and Treatment, November 2023
DOI 10.2147/ndt.s433207
Pubmed ID
Authors

Chanda Simfukwe, Su-Hyun Han, Ho Tae Jeong, Young Chul Youn

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 33%
Lecturer 1 17%
Student > Ph. D. Student 1 17%
Unknown 2 33%
Readers by discipline Count As %
Computer Science 1 17%
Agricultural and Biological Sciences 1 17%
Medicine and Dentistry 1 17%
Neuroscience 1 17%
Unknown 2 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#3,173,174
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#419
of 3,120 outputs
Outputs of similar age
#50,176
of 361,530 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 21 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.